IP Library Granted Patent US 8,298,145
Granted Patent B2
US 8,298,145 · App. 11/775,452 · Granted Oct 30, 2012

Peri-capsular fibroid treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,298,145
App. No.
11/775,452
Granted
Oct 30, 2012
Kind
B2
Abstract

Uterine fibroids and other tissue masses are treated using an electrode or other treatment element introduced into a potential or peri-capsular space surrounding the fibroid under ultrasonic imaging. A therapy is delivered into the potential space by the treatment element in order to reduce or eliminate blood supply to the fibroid or other tissue mass.

Claims (33)

1. A method for treating a tissue mass in a tissue bed, wherein the tissue mass is surrounded by a potential space which lies between the tissue mass and the tissue bed, said method comprising:

penetrating at least one energy delivery element through the tissue bed to position a distal end of the element in the potential space, wherein said penetrating is performed under ultrasonic visualization and wherein said element does not penetrate into said tissue mass;

delivering a therapy through said element into the potential space to reduce blood supply to the tissue mass.

2. A method as in claim 1 , wherein the tissue mass is selected from the group consisting of fibroids and benign tumors.

3. A method as in claim 2 , wherein the tissue mass comprises a uterine fibroid and the tissue bed comprises a uterine wall.

4. A method as in claim 1 , wherein positioning the element comprises advancing the element from a shaft through the tissue bed and into the potential space, wherein the element is advanced through the potential space without entering the tissue mass or reentering the tissue bed.

5. A method as in claim 1 , wherein the tissue mass is a uterine fibroid surrounded by a peri-capsular space present in a uterine wall and the shaft is located in a uterus.

6. A method as in claim 1 , further comprising ultrasonically imaging the tissue mass while the at least one element is being positioned.

7. A method as in claim 1 , wherein the tissue mass is a uterine fibroid and imaging is carried out from a location in a uterus.

8. A method as in claim 1 , wherein the therapy comprises delivering energy selected from the group consisting of electrical energy, thermal energy, and mechanical energy.

9. A method as in claim 8 , wherein the energy comprises electrical energy.

10. A method as in claim 9 , further comprising injecting an electrolytic fluid into the potential space before or during delivering the electrical energy.

11. A method as in claim 9 , wherein the therapy comprises delivering a therapeutic agent into the potential space without penetrating said tissue mass.

12. A method as in claim 11 , wherein the therapeutic agent comprises a heated fluid.

13. A method as in claim 11 , wherein the therapeutic agent comprises a cryogenic fluid.

14. A system as in claim 9 , wherein the electrical energy comprises RF.

15. A method as in claim 8 , wherein the energy delivery comprises delivering a substance selected from the group consisting of liquid, vapor and gas.

16. A system for delivering energy to a potential space surrounding a tissue mass present in a tissue bed, said system comprising:

a shaft;

an ultrasonic imaging transducer disposed to image a field of view adjacent a distal portion of the shaft; and

a treatment element advanceable from a distal end of the shaft, wherein the element is adapted to enter and follow a path in the potential space, wherein the treatment element comprises a curved ribbon having a blunt end with a conductive surface along an inner radius and an insulating surface along an outer radius.

17. A system as in claim 16 , wherein the shaft is rigid.

18. A system as in claim 17 , wherein the ultrasonic transducer is disposed to view laterally from the shaft and the element is advanceable into a field of view provided by the ultrasonic imaging transducer.

19. A system as in claim 18 , wherein the treatment element advances from a distal port on the shaft and curves into the field of view of the imaging element.

20. A system as in claim 19 , wherein the blunt end is adapted to follow the outer surface of the tissue mass in the potential space.

21. A system as in claim 16 , wherein the treatment element comprises an electrode for delivering electrical energy.

22. A system as in claim 21 , wherein the electrical energy comprises RF.

23. A system as in claim 16 , wherein the treatment element comprises a lumen for delivering a therapeutic agent.

24. A system as in claim 16 , wherein the treatment element has a sharpened edge for excising blood vessels surrounding the tissue mass.

25. A system as in claim 16 , wherein the treatment element is configured to advance along a curved path to help follow the curvature of the potential space.

26. A system as in claim 16 , wherein the treatment element further comprises a pressure transducer near a distal tip.

27. A system as in claim 26 , wherein the treatment element further comprises a fluid infusion port located to release fluid into the potential space when the pressure transducer is within the potential space.

28. A system as in claim 16 , wherein the treatment element comprises an electrode for delivering one of liquid, vapor and steam.

Assignments (6)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 070236/0154 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GYNESONICS, INC.
Reel/Frame 075455/0789 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Feb 14, 2025
From: GYNESONICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 070236/0154 →
RELEASE OF SECURITY INTEREST Recorded Oct 18, 2010
From: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
To: GYNESONICS, INC.
Reel/Frame 025151/0672 →
SECURITY AGREEMENT Recorded Nov 19, 2009
From: GYNESONICS, INC.
To: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
Reel/Frame 023547/0205 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: DECKMAN, ROBERT K.; GERBI, CRAIG; MUNROW, MICHAEL; BAJOR, JORDAN; GROSSMAN, JESSICA
To: GYNESONICS, INC.
Reel/Frame 019693/0050 →